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Major  histocompatibility complex  (MHC)~-encoded  gene  products  are  inti- 
mately involved in a  variety of immune responses associated with both antigen 
recognition and alloreactivity. The class  I  molecules are 45,000  mol wt mem- 
brane glycoproteins associated with a  12,000  mol wt protein,/32-microglobulin. 
These  proteins  are  composed  of three  external  domains  (0/1, 0~2, and  0/3), a 
transmembrane portion, and an  intracytoplasmic carboxyl terminus. The first 
two external domains are extremely polymorphic (1). These polymorphic regions 
are considered integral in immune response gene control and MHC restriction. 
A  more  precise  understanding of the  structure-function relationships of the 
MHC class I molecules is critical to understanding immune recognition. Several 
different approaches have been  used to investigate the topographic and func- 
tional locations of these polymorphic determinants using cytotoxic T  cells (CTL) 
and alloantibodies. These include: (a) the examination of in vivo (2-4) and in 
vitro (5, 6) derived class I mutants; (b) differential blocking of CTL activity with 
anti-H-2 monoclonal antibodies (mAb) (7); and (c) most recently, gene transfer 
studies, in which native (8-10)  or exon-shuffled MHC genes were transfected 
into L cells (11,  12-14).  Gene transfer studies (11,  12), in which H-2L  a and H- 
2D  ~ genes  have  been  split,  exon-shuffled, recloned  in  bacteria  and,  finally, 
transfected into  L  cells,  have shown that  the specificities recognized by most 
mAb are determined by the al and/or 0/2 domains of these products, although 
occasional mAb recognize epitopes associated with the ~3 domain. By comparison, 
all CTL clones and bulk cultures analyzed to date react with epitopes associated 
with the 0/1  and/or  0¢  2  domains (13).  Recently, we reported the generation of 
new hybrid class I constructs in which either the 0/1 and 0/2 domains of K  b and 
D b had been exchanged as a unit or in which the 0/1  domains of K  b and D  b had 
been  exchanged (11).  These  new  hybrid molecules are  illustrated in  Fig.  1. 
Analysis of these Kb/D  b hybrids using alloreactive and influenza-specific CTL 
suggested that CTL recognition of conformational determinants was dependent 
l Abbreviations used in this paper:  Con A, concanavalin A; CTL, cytotoxic  T lymphocytes;  FCS, 
fetal calf  serum; FMF,  flow microfluorometry;  HBSS, Hanks'  balanced  salt solution; IFN, interferon; 
IL-2, interleukin 2; mAb, monoclonal  antibody;  MHC, major histocompatibility  complex; tk, thymi- 
dine kinase; Ltk-, thymidine  kinase-deficient  mouse L cells. 
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on  both  the  al  and  OL2  domains.  However,  a  number  of mAb  recognized  the 
hybrid  constructs  as  well  as  they  recognized  the  native  molecules;  these  mAb 
may represent a minor population of domain-specific alloreceptors. In the present 
study we examined  the  recognition  of the  Kb/D  b hybrids with  CTL  generated 
against  K b or  D b by cells from  H-2  b mutant  mice,  which  have  few amino acid 
changes in either the aj  or  OL  2  domains of K b or D b. These populations might be 
expected  to  react  with  determinants  expressed  on  single  MHC  domains.  In 
addition, CTL clones were examined as an approach to identify al or o~2 domain- 
specific T  cell  populations.  We  demonstrate  that  the  exchange  of al  domains 
between K b and D b generates new antigenic determinants that can be recognized 
by CTL. 
Materials and  Methods 
Animals.  C57BL/10  (B10), C3H/HeJ, B6.CH-2 bin1, and B6.CH-2  bm~ mice were pur- 
chased  from  The Jackson  Laboratory  (Bar  Harbor,  ME).  B6.CH-2 bin6, B6.CH-2  brow, 
bm I 1  bin8  B6.CH-2  , and B6.CH-2  mice were kindly provided as breeding pairs by Dr. R.J. 
bml3  bml4  Melvoid (Chicago, IL) and bred in our colony. B6.CM-2  and B6.CH-2  mice were 
kindly provided by Dr. I. McKenzie (Melbourne, Australia) and bred in our colony. 
mAb.  The mAb and their known specificities have been described previously (15,  16). 
mAb EH-144, provided by Dr. T. V. Rajah (Bronx, NY), was derived from a C57BL/10- 
immunized BALB/c mouse, is specific for H-2K  b, and crossreacts on H-2  p'~. 
Interferon  Treatment.  Partially purified mouse fibroblast 7  interferon (IFN-'y) (sp act, 
5 x  107 U/rag protein) was a gift from Dr. Suzanna Serrate (Department of Pathology, 
U. S.  Uniformed Health Services). L cells were cultured as monolayers in  75-cm  ~ tissue 
culture flasks with 10,000 U of IFN-% After 24 h the cells were harvested and prepared 
for flow microfluorometry (FMF) analysis or as target cells for lysis by CTL. 
Construction  of Hybrid H-2 Genes and Transformation  of Mouse L  Cell Fibroblasts.  The 
construction of the four hybrid class I genes was described previously (11).  Briefly, the K  b 
and D b second exons were isolated from the whole genes as 330 and 390 base pair (bp) 
fragments, respectively, and inserted directly into the heterologous gene from which the 
second exon was deleted. The exchange of promoter and exons 1, 2, and 3 between K  b 
and D b was performed by, first, isolating these regions as 1,800 and 1,850 bp fragments, 
respectively. These fragments were relegated to K  b and D  b 3' gene fragments. Ligated 
DNA  were  introduced  into  CaCle-treated  Escherichia  coli DH1  or  HBI01  cells  (17). 
Colonies were picked and  constructs  were  identified  by restriction  enzyme digests on 
plasmid mini-preps. DNA for transformation of thymidine kinase (tk)-deficient mouse L 
cells  (H-2  k)  (Ltk-) was  isolated  from plasmid maxi-preps.  Exon  exchange  and  correct 
orientation of insertion was confirmed by restriction mapping. 
Ltk- cells were cotransformed with the K b, D b, or one of four Kb/D  b hybrid genes and 
a  plasmid  containing  the  tk  gene,  by  CaPO4  coprecipitation  (18).  Cloned  cell  lines 
expressing high  levels of K ,  D b, and hybrid Kb/D  ~ antigens were selected for further 
study (Fig.  1). The L cell line expressing the normal D b product as well as some of the L 
cells expressing hybrid MHC molecules were unstable, as seen by a bimodal fluorescence 
intensity distribution (data not shown). Therefore, for the CTL studies, several lines were 
recloned before use. 
Immunofluorescence Staining and FMF.  Cell surface antigen expression by L cells was 
studied by FMF analysis as previously described (19),  using a fluorescence-activated cell 
sorter  (FACS  II;  Becton  Dickinson  Immunocytometry Systems,  Mountain  View,  CA) 
interfaced to a  PDP  11/34  computer (Digital Equipment Corporation, Marlboro, MA). 
Monolayer cultures of L cells were harvested by trypsinization and washed three times in 
Hanks' balanced salt solution (HBSS), 0.1% sodium azide, and 10% fetal calf serum (FCS). 
106 cells were incubated with 25 ILl of culture supernatant or ascitic fluid (1:100) of mAb. 
After incubation with mAb at 4°C for 45 rain, the cells were washed and stained with 25 
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FICURE  1.  Cell lines expressing hybrid MHC gene products are illustrated. Genes encoding 
the  three  external  domains are designated cq,  a2,  and  c~,  while M  and  I  represent  the 
transmembrane portion and intracytoplasmic portion of the molecule, respectively. 
ville, PA). Fluorescence intensity was assessed by FMF, analyzing 2-5 x  104 stained cells 
using logarithmic amplification.  Fluorescence data are depicted as the percent median 
fluorescence relative to the L cell expressing the native MHC molecule. 
Generation  of K b- and Db-specific CTL Populations.  Primary and secondary CTL popu- 
lations were generated as previously described (6). Briefly, 5  X  106 responder cells were 
mixed with 2-4 x  106 irradiated (2,00 rad) stimulator cells in 2 ml final volume complete 
media (RPMI  1640 supplemented with  10%  FCS, sodium pyruvate, nonessential amino 
acids, glutamine, penicillin-streptomycin, and 2-mercaptoethanol). In some experiments, 
irradiated (10,000  tad)  L  cells were  used as stimulator cells at concentrations ranging 
from 5 x  103 to 105 cells per 2-ml cultures. In some studies responder cells were obtained 
from animals primed in vivo with the transfected L cells (107 cells, intraperitoneally). The 
mixed lymphocyte cultures were incubated at 37°C in  10% C02/90% humidified air for 
5  d.  After  5  d  of culture,  the  effector cells were  harvested,  resuspended  in  complete 
media, counted,  and  then  either replated as a  secondary culture at  2  x  106  responder 
cells and 5 x  106 stimulator cells in 2 ml complete media or assayed for CTL activity in a 
~Cr release assay. Secondary cultures were supplemented with  10% interleukin 2 (IL-2)- 
containing, lectin-free, concanavalin A (Con A) supernatant as previously described (5). 
5~Cr Release AssaY  5.  Target cells were radiolabeled by incubating 2-4 x  106 tumor cells 
with 250 #Ci of Na  ~Cr in 0.5 ml of FCS. 25 #1 of radiolabeled target cells were added to 
effector cells in a  total volume of 225  t~l in  U-bottomed microtiter wells. After  1-2  h, 
target cells were  washed  three  times in  HBSS,  counted,  and  resuspended  in  complete 
media. The plates were  incubated for 5  h  at 37°C.  Supernatants were harvested  using 
the  Titertek  supernatant  collection system  (Skatron,  Inc.,  Sterling,  VA).  The  percent 
specific lysis was calculated as follows: percent specific lysis =  [(experimental release (cpm) BLUESTONE ET  AL.  271 
-  spontaneous release)/(total release (cpm)  -  spontaneous release)]  ×  I00, where total 
release represents cpm released after incubation with 0.1 N HCI. 
CTL Clones.  Cloned CTL were produced by methods described in detail elsewhere 
(5). Briefly, cells  from  2 °  or  3 °  one-way mixed lymphocyte cultures  were  cloned by 
limiting dilution at one cell per well in the presence of 5 ×  105 spleen cells (3,300 rad) in 
5-10%  of a  50:50  mixture of lectin-free Con  A  supernatant and  phorbol  myristate 
acetate-induced EL-4 factor in flat-bottomed, 96-well  microtiter plates. After 7-10  d, 
growth-positive wells were screened for cytotoxicity in a 4 h 5~Cr release assay. All clones 
used in these studies had been subcloned at 0.3 cells per well with a  60-85%  cloning 
efficiency. 
Results 
Examination of Polymorphic Determinants Using CTL Derived Across H-2  b Mutant 
Anti-H-2  b Combinations.  Cytotoxic T  cells generated against class I antigens have 
been shown to be highly heterogeneous by clonal analysis (3, 5) and by the ability 
of mAb that react with different epitope clusters to differentially inhibit CTL 
activity (7).  However, in some instances, certain  mAb specific for one domain 
inhibit  the  majority  of  CTL.  These  results  suggested  that  CTL  react  with 
specificities determined  by  the  conformation of the  whole  H-2  molecule,  not 
solely the al or 0/2 domains. Several investigators (2, 3) have shown that some H- 
2K  b mutant anti-Kb-specific CTL recognize fewer allodeterminants than conven- 
tional  allo-CTL  populations.  In  some  cases,  the  determinants  recognized  ap- 
peared to be influenced by both the 0/1  and az domains (3).  However,  unique 
domain-specific structures may also be recognized. With this in mind, alloreactive 
bulk CTL and CTL clones were  generated across a  variety of H-2K  b mutant 
strain combinations.  In some combinations, such as the bin8 and bin3 anti-K  b, 
the amino acid differences between the mutants and the wild-type K b molecule 
resided in the at domain. In contrast, the bm 10 and bm 1 mice differed from K b 
in amino acids localized to the 0/2 domain. Using a series of primary, secondary, 
and cloned CTL populations, we detected no lysis of the L cells expressing the 
hybrid H-2 antigens in which the a~ domains of K b and D b are  exchanged (Fig. 
2 and Table I). Clearly, the CTL examined in Fig. 2, top are specific for H-2K  b, 
since they lyse K b- but not Db-transfected L cells. However, no lysis was detected 
of either the Kb/D  b- or Db/Kb-transfected L  cells.  Alloreactive CTL were also 
generated using H-2D  b mutant mice as responders  (bml3  and bml4).  Fig.  2, 
bottom illustrates the results of such experiments, in which Db-specific CTL lysed 
D b and  Db+2/K b  transformants but failed to iyse  L  cells expressing the hybrid 
genes Kb/D  b or Db/K  b.  As previously shown, all L  cells were equally lysable, as 
shown by their susceptibility to anti-H-2 k CTL. 
Lack of Recognition of Hybrid Molecules With Exchanged  0/1 Domains by Conven- 
tional Alloreactive CTL.  The present study, using a  much larger panel of bulk 
culture and cloned CTL, confirmed the earlier result (11) that the hybrids Kb/ 
D b and Ob/K  b are not recognized by K b- or Db-allospecific CTL although the L 
cells were equally lysable by anti-H-2 k effector CTL (Table  I). One reason for 
the  lack of lysis could have  been  the  lower  level  of expression  of the  hybrid 
molecules by the L cell transfectants (Table II). To address this possibility, L cell 
transfectants were cultured for 24 h with IFN-3,, which increases MHC expression 
in transfected L  cells (20).  However, even under conditions in which the levels 272  CTL  RECOGNITION  OF  HYBRID  MHC  MOLECULES 
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FIGURE 2.  Alloreactive CTL were analyzed for reactivity on L cell transformants. CTL lines 
were derived by restimulation of responding ceils for three cycles before assay. 
of expression of hybrid H-2 were almost equivalent (>90% of control) to the L 
cells transfected  with  the native  molecule,  no lysis  was detected by serological 
analysis (Table III). Therefore,  it appears that the determinants  recognized by 
the alloreactive CTL were altered by the exchange of the ~  domains or that the 
CTL did not recognize isolated determinants of the ~  or ~2 domains. 
Expression  of Neoantigenic  Determinants  on  Hybrid  MHC  L  Cell  Transform- 
ants.  Although the L cells expressing the hybrid MHC molecules appeared to 
be good targets for CTL lysis (i.e., anti-H-2 k CTL lysed the  L cells), it was not 
clear that the hybrid molecule was expressed by the L cell in sufficient quantity 
or in a conformation that could be recognized by CTL. To address this possibility, 
we attempted to generate CTL against the transformed L cells. If new antigenic 
determinants that were not present on H-2D  b products had been created by the 
interaction of the c~ and ot~ domains of D b and K b, respectively, then (H-2  b ×  H- 
2k)F~ CTL generated against the transformants might react with the new deter- 
minants.  (C3H/HeJ x  C57BL/10)F1 spleen cells were stimulated against L cells 
expressing the hybrid gene D~/K  b. In preliminary experiments (data not shown), 
stimulation with L cells resulted in nonspecific lysis of tk  + L cell control. However, 
pretreatment  of the responder cells with anti-L3T4  plus complement, or Seph- 
adex  G-10  depletion  of responder  macrophages  (21)  appeared  to  lower  the 
nonspecific lysis. Therefore, we performed an experiment using responding cells 
that had undergone  both treatments  (Fig.  3A).  It is clear from the results that 
FI cells stimulated with the Db/K  b transformant generated CTL reactive against 
the  D~b/K  b transformants.  No  lysis  of  Kb-transfected  L  cells  was  seen.  mAb BLUESTONE  ET  AL. 
TABLE  I 
Reactivity of K b' and Db-specific CTL Clones on Transformants 
CTL  Population 
Targets (percent specific lysis)* 
K b  D b  K~/D  b  D~/K  b 
3 °  Lines  * 
B10 anti-B10.BR  0 (anti-KkD  k)  32.3  36.4  42.3  66.8 
Bt0.BR anti-B10 (anti-KbD  b)  44.6  22.4  -1.3  2.1 
C3H/HeJ anti-C3H.KBR (anti-  52.3  -1.6  2.8  3.7 
K  b) 
B10.BR anti-B10.A(2R) (anti-D  b)  1.6  42.9  0.1  -4.2 
CTL Clones  I 
C3H/H3J anti-C3H.KBR-1  41.3  1.9  -2.2  1.6 
-3  32.6  4.6  -3.4  2.7 
-5  48.4  3.8  0.1  -1.1 
-13  18.1  -1.1  4.1  -1.3 
-19  22.3  --1.9  -1.6  4.2 
-22  29.4  6.6  3.2  2.7 
BM10 anti-B 10-5  44.8  1.3  2.6  4.1 
-6  36.3  2.1  1.4  -2.6 
-37  26.1  -1.8  -2.3  3.0 
-38  44.7  3.7  4.3  -3.0 
-42  24.8  1.0  1.6  1.4 
BM8 anti-B10-5  32.6  -6.6  -4.8  -3.7 
-13  46.2  1.3  1.7  -0.3 
*  Percent specific lysis relative to medium. 
* Effector/target ratio,  33:1. 
§ The  MHC haplotypes of the mouse strains used to generate the CTL 
were:  C3H/HeJ,  KklkDk;  C3H.KBR,  kbIbDk;  B10.BR,  KalkDk; 
B10.A(2R), Kk,I~,Db; and B10, KbIbD  b. 
I Effector/target ratio, 2:1. 
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TABLE  II 
Binding of Anti-H-2 mAb to L Cells Transfected  With Hybrid MHC Genes 
mAb 
Antibody binding (percent fluorescence)* hybrid molecules 
K b  K~+2/D  b  K~/D  b  D~/K  b  D~+2/K  b  D k 
Domain 
specificity 
20-8-4  100  116  46  0  0  0 
EH-144  100  108  72  0  0  0 
B8-3-24  I00  130  32  0  0  0 
5F1  100  122  0  61  0  0 
28-13-3  100  136  0  63  0  0 
34-4-20  100  106  0  27  0  0 
K9-178  100  118  0  25  0  0 
K9-136  100  142  0  0  0  0 
B22-249.1  0  0  71  0  98  100 
28-11-5  0  0  0  30  96  100 
H14t-31  0  0  0  15  79  100 
27-11-13  26  32  13  43  94  100 
28-14-8  0  117  70  0  0  100 
H141-29  0  0  0  0  103  100 
K b ctl 
K b al 
K b al 
K b a~ 
K b o~2 
K b or2 
K b or2 
K  b a~/a~ 
D b t~ 
D b oq 
O b  oq 
KbS  b  oil 
D b  o/3 
D b al/a2 
* Values normalized relative to binding of native molecule. 274  CTL  RECOGNITION  OF  HYBRID  MHC  MOLECULES 
TABLE  III 
Effect of lFN-~, on H-2 Expression and CTL Recognition 
Percent lysis 
Target cells (effector/target, 20:1 ) 
D  b  Dbl *  Db/K  b  Db/Kbl  Kb/D  b  K~/Dbl 
BM3 anti-B10 (anti-K  b) 
BR anti-B 10 (anti-KbD  b) 
B10 anti-B10.A(2R) (anti-D  b) 
BM 14 anti-B 10 (anti-D  b) 
B10 anti-BR (anti-KkD  k) 
1.5  -1.8  5.5  -2.9  -10.1  4.1 
30.9  21.2  -1.7  -4.2  -3.1  -1.2 
60.1  73.7  5.6  -5.9  4.2  1.2 
51.1  31.9  -3.4  2.4  -5.0  -0.9 
32.2  21.8  46.7  33.6  38.1  40.7 
Fluorescence intensity* (mV -1) 
925.1  2167.5  ND  ND  329.8  863.1 
* IFN-7 treated as described in Materials and Methods. 
* Cell lines were stained with 28-14-8  mAb. ND, not determined. 
RESPONDER:  (B10 ~ C3H)F1 
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FIGURE 3.  Generation of CTL derived against neodeterminants expressed on hybrid class I 
antigens. Fl mice were primed in vivo with 107 L cell transformants 1 wk before in vitro assay. 
Mab (28-11-5 and H141-11  for D  b a~; 5F1 and 28-13-3  for K  b ~2; 20-8-4 and EH-144 for K  b 
a~; and B22-249.1  for D  bal) were incubated with target before the addition of effectors (B). 
blocking, using anti-D  b or -K  b antibodies specific for the a~  or a2 domain  of H- 
2, confirmed  the specificity of the CTL  generated  (Fig. 3B).  Either anti-Dbr  or 
anti-K~2-specific mAb  blocked CTL  function  at the effector phase.  These  anti- 
bodies had  no  effect  on  the  lysis of the  same  L  cell transfectants  by anti-H-2 k 
CTL  (data not shown). 
Alloreactive CTL From Bulk Culture and CTL Clones Do Not Recognize Polymorphic 
Determinants  on  the  as  Domain  of the  Hybrid  MHC  Molecules.  We  previously 
reported  (1 1) that allogeneic CTL  generated  against  K b and  D b locus products 
efficiently  lyse  Kb+2/D b  and  D~+2/Kb-transfected  L  cells,  respectively.  These 
results  suggested  that  the  majority  of  CTL  recognize  polymorphic  regions 
determined  by the a~ and a2 domains.  It was possible, however, that a  minority 
of cloned CTL  populations recognize the as domain.  We have tested here >20 
Kb-specific CTL  clones derived in different alloreactive combinations  on  the  L 
cell transfectants.  All CTL  that react with  Kb-transfected but not Db-transfected 
L  cells recognized polymorphic  sites localized to the a~/a2 domains (Table IV). BLUESTONE  ET  AL. 
TABLE  IV 
Reactivity of Kb-spec~c  CTL Clones on L Cell Transformants 
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Percent specific lysis* 
CTL Clone*  Target (effector/target, 33:1) 
K b  D b  K~+~/D b  D~+2/K b 
C3H/HeJ anti-C3H,KBR- 1  24.3  -0.7  29.1  0,1 
-3  46.4  3.8  36.3  4,0 
-5  23.3  -1.8  26.4  2.1 
-13  37.1  -0.2  31.9  -1.6 
-19  26.8  -6.1  21.3  -1.4 
-22  42.9  3.3  44.9  3.8 
B10.GD anti-B 10-3  50.2  1.8  62.3  -1.0 
-9  19.9  4.6  23.3  1.4 
-10  31.3  -2.2  21.6  2.3 
* Each clone examined at  [east  three times. For simplicity, data from different experiments have 
been compiled into a single table. 
* Percent specific lysis of each clone relative to medium. 
In addition,  limiting dilution analysis of Kb-specific CTL showed no or3 recogni- 
tion (data not shown). Thus, apparently no CTL were detected that recognized 
the ~3 domain; in contrast, mAb specific for this domain have been defined (10, 
11). 
Localization  of Serological Determinants on Mouse Hybrid MHC Molecules.  Pre- 
viously (11),  transformed  L  cell  lines  expressing  K b,  D b,  or  the  hybrid class  I 
molecules resulting from exon exhanges were analyzed by radioimmunoassay to 
map the mAb-binding specificity. However, fluorescence analysis suggested that 
some of the transformant's lines were composed of mixed populations expressing 
different levels of H-2 antigens.  This result could explain the lower binding of 
some mAb to the transfectants expressing the hybrid MHC antigens. Therefore, 
several of the L cell lines were recloned, and transformant clones that exhibited 
unimodal fluorescence profiles were reexamined to confirm the binding specific- 
ity of several  of the  anti-H-2 b mAb  previously studied  and  to  determine  the 
binding specificity of five additional anti-H-2 b mAb. In accordance with previous 
results (11), the majority of the mAb bound to polymorphic sites determined by 
the al and/or  a2 domains (Table II).  Most of the Kb-specific mAb bound the L 
cell line expressing the Kb+z/D  b hybrid molecule to a greater extent than the K b, 
due to more MHC antigen  on the cell surface (data not shown). As previously 
reported  (11),  one  mAb,  28-14-8,  demonstrated  significant  binding  to  L  cells 
transfected with D b or K~+2/D b, mapping its reactivity to the o~3 domain. 
The binding of the mAb was next analyzed on the ~1 hybrid gene transformants 
(Kb/D  b and Db/Kb). Binding of all mAb to L cell transformants  with H-2 genes 
in which the 0/~ domains were exchanged was significantly lower than binding to 
L cells expressing the native molecule (Table II). Since the binding of 28-14-8, 
an c~3-specific anti-D  b mAb, was unaffected by substituting K b in both the a~ and 
0/2  domains  (Table  lI)  but  was  significantly  lower on  the  Kb/D  b transfectants 
(70%  of control),  it  seemed likely that  this  transfected  L  cell  expressed  fewer 276  CTL  RECOGNITION  OF  HYBRID  MHC  MOLECULES 
hybrid molecules on the cell surface. Scatchard analysis using Fab of 28-14-8 (ols 
specific)  showed  somewhat fewer  hybrid  MHC  molecules on  the  K~/D  b cells 
compared with the L  cells  transfected with either the native molecule (D  b)  or 
Kb+2/D  b (Table V).  In addition, the binding of mAb 20-8-4,  specific for the at 
domain of K b,  showed a  lower  binding affinity, suggesting a  conformational 
alteration of this molecule as  well  (Table  V).  However, with the exception of 
mAb K9-136 and 27-I 1-13,  all the mAb binding could be mapped to either the 
o~  or  az  domains of K b  and the hierarchy of reactivity among the  mAb  was 
similar to that reported previously (11).  27-11-13  was found to bind K  b and D  b, 
in contrast to previous findings (15).  However, the titer on  K  b was much greater 
than D  b.  Since 27-11-13  bound Kb/D  b better than the Db/K  b transfectant, this 
mAb has been  tentatively mapped to the a~  domain. Therefore, as previously 
reported (11),  the majority of Kb-specific mAb are directed at the polymorphic 
sites determined by the  o~,  and/or  Og  2  domains.  The  interaction of these  two 
domains appears critical for optimal binding; the conformation of domains 1 and 
2 in the Kb/D  b and D~/K  b hybrids seem to differ from that in the parental. 
Discussion 
In recent years biochemical and genetic analysis have been used to examine 
the structure of the H-2 class  I  molecule. The as domain of class  I  molecules 
interacts with/32-microglobulin, while the oq and ~2 domains appear to express 
the polymorphic sites involved in  allorecognition and  MHC  restriction  of re- 
sponses to foreign antigens by T  cells  (1).  However, the precise localization of 
the amino acid sequences recognized by T  cells  or alloantibodies have not yet 
been  determined.  It is  these  polymorphic sites  that appear  to  be  recognized 
during an immune response. The advent of gene splicing techniques has allowed 
the  construction of hybrid  H-2  class  I  genes.  These  new  genes  can  then  be 
expressed as novel class I molecules after transformation into mouse fibroblasts. 
Initial studies of allodeterminants expressed by these L cells has been hindered 
by the  heterogeneity of bulk CTL generated across  a  fully allogeneic class  I 
difference. Mouse strains exist with mutations restricted to the first and second 
domains (1) and may be useful to study limited MHC differences (3).  Previous 
TABLE  V 
Analysis of Binding of Anti-H-2 mAb to L Cell Transformants 
R* (molecules/  K* (M -1 X  10  -8)  Cell line  mAb (Fab)  cell x  10  4) 
D b  28-14-8  8.7 4- 0.6  2,2 +  0.1 
K~+~/D  b  28-14-8  10.1  +  0.9  2.3 _+ 0.2 
20-8-4  9.4 +  0.7  6.2 4- 0,5 
K~/D  b  28-14-8  4.1  4- 0,2  2.0 4- 0.1 
20-8-4  3,3 4- 0.4  .73 4- 0.08 
* The  number of antibody  molecules bound on  a  cell  at saturation (R) 
and the binding affinity (K) were determined as described (24) by fitting 
data to the equation: r =  RK.(Ab)/1  +  K(Ab), where r  is the number of 
antibody molecules bound per cell, (Ab) is the free antibody concentra- 
tion, and R is a measure of the average number of antigenic determinants 
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analysis (5)  of these  mutant  MHC  molecules  has  provided  insights  into  the 
structure/function relationship of class  I molecules. Using H-2K  b mutant mice, 
it  has  been  possible  to  examine  the  allodeterminants  recognized  by  T  cell 
populations and to compare them with allodeterminants revealed by anti-H-2 
antibodies. Because of these advantages, the H-2K  b and D  b genes were isolated, 
the external Otl and o~2 domains exchanged, and the new class I genes transfected 
into mouse L cells. 
We have confirmed in this study that CTL and alloantibodies recognize L cell 
lines transfected with H-2K  b and D b genes to the same extent as they recognize 
native proteins on splenocytes. However, no alloreactive CTL could be identified 
that recognize the L cells expressing hybrid molecules in which the al domains 
of  K b  and  D b  were  exchanged.  This  lack  of lysis  was  observed  using  CTL 
generated from H-2K  b and D b mutant mice in response to wild-type H-2K  b and 
H-2D  b antigens. Since a number of these mutants involve amino acid changes in 
only a  single domain, it  might have been  expected that these CTL would be 
predominantly specific for determinants localized to a  single MHC domain (2, 
3).  However,  studies  using  the  K b  mutants  have  shown  that  the  amino acid 
changes in one domain often alter the CTL recognition of another domain (2, 
3). Therefore, the failure of these CTL to react with the hybrid gene products 
is consistent with these previous results.  One concern in the present study was 
the reduced binding of an ors-specific mAb to L cells transformed with the hybrid 
molecule due to significantly less  H-2 antigen on the cell surface. To rule out 
the possibility that these cells expressed too few MHC molecules to allow lysis by 
the CTL, the L cells were cultured with IFN--y, which augmented MHC expres- 
sion two to threefold. Even under these conditions the transformed L cells were 
not lysed by CTL. Another concern was that the inability to lyse the transform- 
ants was due simply to an altered cell surface expression of the hybrid molecules. 
Perhaps  the  class  I  molecule  does  not  associate  with  other  cell  interaction 
molecules required for CTL recognition or perhaps the tertiary structure was 
completely destroyed. This latter possibility seems unlikely since the binding to 
the hybrid molecules by several  mAb was  unaltered and one hybrid molecule 
(D~/K  b)  was  able  to  act  as  a  target  for  CTL  generated  against  it.  In  most 
experiments, in vivo priming was required, suggesting that the CTL precursor 
frequency for the hybrid molecule was significantly lower than  that  seen  for 
conventional class I antigens. 
These findings are in contrast to those recently reported by Murre et al. (12), 
in which determinants localized to the 0~1  or  Ot  2  exons from the H-2L  d and H- 
2D  d MHC genes were shown to function as targets for CTL recognition. The 
reason for this disparity is not clear but may represent differences in the genes 
chosen for the exon exchanges. Perhaps in the Ld/D  d system, more allodetermi- 
nants are conserved in the hybrid molecules. 
In this study, CTL clones were examined for as recognition, since mAb specific 
for this domain have been defined (11,  14). To date, no allospecific CTL clones 
generated across a  conventional class  I  (a total of 23) or H-2  bm (a total of 19) 
mutant difference has been shown to recognize determinants encoded by the as 
domain. These finding are consistent with the localization of most of the amino 
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However, the mechanism underlying the failure ofalloreactive CTL to recognize 
the ~  domain is unclear. One possibility is that the repertoires of T  and B cells 
differ so that T  cells fail to recognize determinants expressed by the a3 domain. 
These differences may alternatively reflect steric considerations.  Since CTL are 
much  larger  than  antibodies,  the allogeneic sites within  the  a3 domain  of the 
native MHC molecule may be inaccessible to CTL. Currently, studies are under- 
way  to  examine  CTL  and  antibody  recognition  of  L  cells  transfected  with 
truncated genes and expressing only the ~3 domain on the cell surface. Finally, 
it is possible that  class I-specific CTL express a  different repertoire  than  mAb 
since  they recognize  native  MHC molecules,  while activation  of antibody-pro- 
ducing  B  cells  may  require  recognition  of processed  antigen  and  accessory 
function  by  class  I-specific  helper  cells  (22).  Therefore,  studies  designed  to 
examine  the  recognition  of the  hybrid  MHC  molecules  by class  I-specific  T 
helper ceils are currently being pursued. 
In the present study there appeared to be a difference between antibody and 
CTL recognition of hybrid MHC molecules in which the ~1 domain of K b and 
D b  had  been  exchanged.  Most of the  mAb  bound to the  cells expressing  the 
hybrid  molecules.  However,  no  alloreactive  CTL  recognized  these  hybrids. 
Several hypotheses can be postulated to explain this difference: (a) the combining 
site  of the  T  cell  receptor  is  larger  than  that  of antibodies,  and  T  cells  are 
therefore more sensitive to pertubations of the MHC molecules. (b) The affinities 
of CTL are significantly lower than those of antibodies and thus more susceptible 
to changes in conformation. This hypothesis is the least complex, since it would 
not  be  necessary  to  invoke  different  repertoires  for  alloreactive  T  cells  and 
antibodies, but this possibility can only be addressed once the relative affinities 
of T  and B cell receptors are known. (c) Perhaps the most attractive hypothesis 
is that  the T  and B cell receptors have different expressed repertoires.  Recent 
molecular analysis (23) of the T  cell receptor genes suggests that  the T  and  B 
cell receptors would appear to be encoded by different genes. The difference in 
T  cell  and  antibody  repertoires  may  reflect  the  fact  that  T  cells  recognize 
different portions of the MHC molecule than do antibodies. For example, CTL 
may recognize an amino acid sequence located at the junction of the ~  and ~z 
domains where some polymorphism has been shown (1). Although this hypothesis 
is consistent with other studies suggesting that T  and B cells recognize distinct 
antigenic determinants (5, 6), the folding of the MHC domains and the location 
of the  MHC hypervariable regions to other areas of the molecule might argue 
against  allorecognition  of this  part  of the  molecule.  An alternative  hypothesis 
that would lead to differences in the T  cell and antibody repertoires was recently 
proposed by Gress and Hodes (24).  In their studies, CTL recognition of H-2K  b 
appeared to he MHC restricted. The MHC restriction appeared to be intramo- 
lecular, in that recognition of H-2K  bin6 by alloreactive CTL required maturation 
of the CTL presursors in an H-2K  b environment. It is possible that the generation 
of the hybrid MHC molecules results in a loss of the restriction elements required 
for CTL but not antibody recognition. 
In any case, it would appear that the CTL target structures are influenced to 
a  greater  degree  by interactions  betwen the  ~  and  0~2 domains  than  are  the BLUESTONE ET  AL.  279 
structures recognized by antibodies. This difference may provide an insight into 
the expressed repertoires of different immune populations. 
Summary 
AIloreactive cytolytic T  cell (CTL) lines and clones have been used to identify 
the sites of polymorphism of antigens of the major histocompatibility complex 
(MHC).  Specific CTL were generated against wild-type H-2 b products by cells 
from H-2 b mutant mice that had one or a  few amino acid changes in either the 
a~  or  a2  domains of the  K b  or  D b  class  I  molecules. These  CTL populations, 
which might be expected to react with determinants expressed on single MHC 
domains, were examined for lytic activity on L cells expressing newly constructed 
hybrid class I  molecules. Transformed cell lines expressing native class I  mole- 
cules or hybrid class I  molecules in which the al and 0/2 domains of H-2K  b had 
been substituted by those domains of H-2D  b were lysed by H-2Db-specific CTL. 
Similarly, all H-2Kb-specific CTL recognized hybrid molecules in which the al 
and a2 domains of H-2K  b were inserted into the H-2D b molecule.  In contrast, 
exchange  of the  0/1  domains  of H-2K  b and  H-2D  b resulted  in  a  total  loss  of 
recognition by K b and Db-specific CTL. These results suggest that the allodeter- 
minants recognized by H-2 mutant CTL are influenced by interactions between 
the 0/~  and  O/2  domains, findings similar to those seen  using conventional allo- 
reactive T  cells (11). These results were compared to the binding of alloreactive 
mAbs, including 5 new mAbs specific for the K b molecules. Finally, it was shown 
that primary and secondary CTL responses could be generated by direct sensi- 
tization  against  hybrid  class  I  molecules,  demonstrating  that  these  molecules 
express neoantigenic determinants recognized by alloreactive CTL. 
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